Please ensure Javascript is enabled for purposes of website accessibility

Canada Marijuana Dispensary Count Tops 1,000 For the First Time

By Eric Volkman - Jul 18, 2020 at 10:47AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The province with the highest tally probably isn't the one you'd expect.

In less than two years after the country legalized recreational cannabis, Canada has reached an important milestone. According to a report in BNN Bloomberg, the country's dispensary count crossed the 1,000 mark as of July 17, landing at 1,010.

Of all the country's provinces and territories, Alberta in the West has the highest number, at 494. No. 2 is the province where some of the highest-quality Canadian cannabis has traditionally come from, British Columbia (211 dispensaries).

Generic marijuana dispensary sign.

Image source: Getty Images.

Due to an ineffective licensing policy in the early days of legalization, the most populous province, Ontario (which also happens to be the home of the capital, Ottawa, and largest city, Toronto) has only 115 marijuana stores. Somewhat incongruously, some of the highest-profile cannabis companies on the stock market are headquartered in the province, including Canopy Growth (CGC -7.39%) and Cronos Group (CRON -3.45%).

Ontario's neighbor Quebec is also light on the dispensary count, with only 43 licensed cannabis stores.

The total number of Canadian dispensaries is set to grow sharply, with the proportions changing quite a bit. 496 dispensaries in Ontario have yet to receive their full licenses from the province, while some industry observers believe that the Alberta retail market is currently saturated and due for rationalization. 

Canada legalized recreational marijuana on the federal level in October 2018. One year later, it also sanctioned derivative products, such as cannabis-laced drinks and gummies, for consumption and sale. Both Canopy Growth and Cronos have products available (and in development) in both the traditional and derivative product segments.

On Friday, in contrast to the gains of the top stock market indexes, Canopy Growth and Cronos shares declined. The former fell by 0.9%, and the latter by 2.2%.

Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Canopy Growth Stock Quote
Canopy Growth
$3.76 (-7.39%) $0.30
Cronos Group Stock Quote
Cronos Group
$3.08 (-3.45%) $0.11

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.